Group B streptococcal infection laboratory tests: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
 
(19 intermediate revisions by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
 
Any newborn with signs of [[sepsis]] should receive a full diagnostic evaluation and receive [[antibiotic therapy]] pending the results of the evaluation, regardless of the maternal Group B Streptococcus (GBS) colonization status.  Well-appearing newborns whose mothers had suspected chorioamnionitis should undergo a limited diagnostic evaluation and receive antibiotic therapy pending culture results.  No routine diagnostic testing for GBS is recommended among well-looking infants unless either the gestational age is <37 weeks or the duration of membrane rupture before delivery was ≥18 hours.<ref name=CDCMMWR>Verani J.R., McGee L, and Schrag S.J. Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from CDC, 2010.[http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5910a1.htm?s_cid=rr5910a1_w CDC.gov]</ref>  The diagnosis of GBS infection is confirmed by the isolation of the organism in either the [[blood]] or the [[cerebrospinal fluid]] ([[CSF]]).


==Laboratory Tests==
==Laboratory Tests==
===GBS Infection in Neonates===
Shown below is a table that summarizes the laboratory tests that are recommended in different scenarios of suspected early-onset GBS infection in neonates.<ref name=CDCMMWR>Verani J.R., McGee L, and Schrag S.J. Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from CDC, 2010.[http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5910a1.htm?s_cid=rr5910a1_w CDC.gov]</ref>
====Infants with Signs of Sepsis====
Any newborn with signs of [[sepsis]] should receive a '''full diagnostic evaluation''' and receive antibiotic therapy pending the results of the evaluation, regardless of the maternal colonization status (class A, level of evidence II).
 
The full diagnostic evaluation should include:
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[Blood culture]] (Blood cultures can be sterile in as many as 15%--33% of newborns with meningitis)
* [[Chest radiograph]]
* [[Lumbar puncture]]
* Culture of the [[cerebrospinal fluid]] (CSF)
 
====Infants Born to Women with Chorioamnionitis====
Well-appearing newborns whose mothers had suspected chorioamnionitis should undergo a '''limited diagnostic evaluation''' and receive antibiotic therapy pending culture results (class A, level of evidence II).
 
The limited diagnostic evaluation should include:
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[Blood culture]]
* No [[chest radiograph]]
* No [[lumbar puncture]]
 
====Well-Appearing Infants Exposed to Inadequate Intrapartum Antibiotics====
 
Well-appearing infants whose mothers had no [[chorioamnionitis]] and no indication for GBS prophylaxis should be managed according to routine clinical care, and '''no routine diagnostic testing''' is recommended.
 
Well-appearing infants of any gestational age whose mother received adequate intrapartum GBS prophylaxis (≥4 hours of [[penicillin]], [[ampicillin]], or [[cefazolin]] before delivery) should be observed for ≥48 hours, and '''no routine diagnostic testing''' is recommended (class B, level of evidence III).
 
For well-appearing infants born to mothers who had an indication for GBS prophylaxis but received no or inadequate prophylaxis, if the infant is well-appearing and ≥37 weeks and 0 days' gestational age and the duration of membrane rupture before delivery was <18 hours, then the infant should be observed for ≥48 hours, and '''no routine diagnostic testing''' is recommended (class B, level of evidence III).
 
If the infant is well-appearing and either <37 weeks and 0 days' gestational age or the duration of membrane rupture before delivery was ≥18 hours, then the infant should undergo a '''limited diagnostic evaluation''' and observation for ≥48 hours (class B, level of evidence III).


The limited diagnostic evaluation should include:
{| style="cellpadding=0; cellspacing= 0; width: 900px;"
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[Blood culture]]
* No [[chest radiograph]]
* No [[lumbar puncture]]
 
Shown below is a tables that summarizes the laboratory tests that are recommended in different scenarios of possible GBS infection.
{|
|-
|-
|'''Scenario''' || '''Recommended Diagnostic Evaluation'''
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 50%" align=center |'''Scenario''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF" align=center |'''Recommended Diagnostic Evaluation'''
|-
|-
|Infants with signs of sepsis || Complete diagnostic evaluation <br>
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Infants with signs of sepsis''' || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Complete diagnostic evaluation''' (class A, level of evidence II)<br>
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[Blood culture]] (Blood cultures can be sterile in as many as 15%--33% of newborns with meningitis)
* [[Blood culture]]  
* [[Chest radiograph]]
* [[Chest radiograph]]
* [[Lumbar puncture]]
* [[Lumbar puncture]]
* Culture of the [[cerebrospinal fluid]] (CSF)
* Culture of the [[cerebrospinal fluid]] (CSF)
|-
|-
| Infants born to women with chorioamnionitis || Limited diagnostic evaluation<br>
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Infants born to women with chorioamnionitis''' || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Limited diagnostic evaluation''' (class A, level of evidence II)<br>
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[Blood culture]]
* [[Blood culture]]
|-
|-
| Well-appearing infants whose mothers had no [[chorioamnionitis]] and no indication for GBS prophylaxis || No routine diagnostic testing
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Well-appearing infants''' <br> ''PLUS'' <br> The mother had no [[chorioamnionitis]] and no indication for GBS prophylaxis || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''No routine diagnostic testing'''
|-
|-
| Well-appearing infants of any gestational age whose mother received adequate intrapartum GBS prophylaxis || No routine diagnostic testing
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Well-appearing infants''' <br> ''PLUS'' <br> The mother received adequate intrapartum GBS prophylaxis || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''No routine diagnostic testing''' (class B, level of evidence III)
|-
|-
| Well-appearing infants born to mothers who had an indication for GBS prophylaxis but received no or inadequate prophylaxis and the infant is well-appearing and ≥37 weeks and 0 days' gestational age and the duration of membrane rupture before delivery was <18 hours|| No routine diagnostic testing
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Well-appearing infants''' <br> ''PLUS'' <br> The mother had an indication for GBS prophylaxis but received no or inadequate prophylaxis <br>''PLUS'' <br> The infant is well-appearing <br> ''PLUS'' <br> Gestational age ≥37 weeks <br> ''PLUS'' <br> The duration of membrane rupture before delivery was <18 hours|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''No routine diagnostic testing''' (class B, level of evidence III)
|-
|-
| Well-appearing infant and either <37 weeks and 0 days' gestational age or the duration of membrane rupture before delivery was ≥18 hours||Limited diagnostic evaluation<br>
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Well-appearing infants''' <br> ''PLUS'' <br>Either gestational age <37 weeks <br> ''OR'' <br>The duration of membrane rupture before delivery was ≥18 hours||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Limited diagnostic evaluation''' (class B, level of evidence III)<br>
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[CBC]] including [[white blood cell]] differential and [[platelet count]]
* [[Blood culture]]
* [[Blood culture]]
|-
|-
|}
|}
In addition to the previous tests, the evaluation of suspected late-onset GBS sepsis requires the analysis of urine specimen collected by either catheterization or suprapubic aspiration.
==Laboratory Findings==
The diagnosis of GBS infection is confirmed by the isolation of the organism in either the [[blood]] or [[CSF]].  Blood cultures can be sterile in as many as 15% to 33% of newborns with meningitis.<ref name=CDCMMWR>Verani J.R., McGee L, and Schrag S.J. Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from CDC, 2010.[http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5910a1.htm?s_cid=rr5910a1_w CDC.gov]</ref>
Other laboratory findings that are indicative of an infection but non-specific to GBS include elevated [[WBC]] and abnormal findings in the [[CSF]] analysis.  [[Thrombocytopenia]] might occur in the case of [[sepsis]].


==References==
==References==
Line 78: Line 50:
[[Category:Streptococcaceae]]
[[Category:Streptococcaceae]]
[[Category:Obstetrics]]
[[Category:Obstetrics]]
[[Category:Infectious disease]]
 
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Pediatrics]]
[[Category:Neonatology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 17:51, 18 September 2017

Group B Streptococcal Infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Group B Streptococcal Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Group B streptococcal infection laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Group B streptococcal infection laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Group B streptococcal infection laboratory tests

CDC on Group B streptococcal infection laboratory tests

Group B streptococcal infection laboratory tests in the news

Blogs on Group B streptococcal infection laboratory tests

Directions to Hospitals Treating Group B streptococcal infection

Risk calculators and risk factors for Group B streptococcal infection laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Any newborn with signs of sepsis should receive a full diagnostic evaluation and receive antibiotic therapy pending the results of the evaluation, regardless of the maternal Group B Streptococcus (GBS) colonization status. Well-appearing newborns whose mothers had suspected chorioamnionitis should undergo a limited diagnostic evaluation and receive antibiotic therapy pending culture results. No routine diagnostic testing for GBS is recommended among well-looking infants unless either the gestational age is <37 weeks or the duration of membrane rupture before delivery was ≥18 hours.[1] The diagnosis of GBS infection is confirmed by the isolation of the organism in either the blood or the cerebrospinal fluid (CSF).

Laboratory Tests

Shown below is a table that summarizes the laboratory tests that are recommended in different scenarios of suspected early-onset GBS infection in neonates.[1]

Scenario Recommended Diagnostic Evaluation
Infants with signs of sepsis Complete diagnostic evaluation (class A, level of evidence II)
Infants born to women with chorioamnionitis Limited diagnostic evaluation (class A, level of evidence II)
Well-appearing infants
PLUS
The mother had no chorioamnionitis and no indication for GBS prophylaxis
No routine diagnostic testing
Well-appearing infants
PLUS
The mother received adequate intrapartum GBS prophylaxis
No routine diagnostic testing (class B, level of evidence III)
Well-appearing infants
PLUS
The mother had an indication for GBS prophylaxis but received no or inadequate prophylaxis
PLUS
The infant is well-appearing
PLUS
Gestational age ≥37 weeks
PLUS
The duration of membrane rupture before delivery was <18 hours
No routine diagnostic testing (class B, level of evidence III)
Well-appearing infants
PLUS
Either gestational age <37 weeks
OR
The duration of membrane rupture before delivery was ≥18 hours
Limited diagnostic evaluation (class B, level of evidence III)

In addition to the previous tests, the evaluation of suspected late-onset GBS sepsis requires the analysis of urine specimen collected by either catheterization or suprapubic aspiration.

Laboratory Findings

The diagnosis of GBS infection is confirmed by the isolation of the organism in either the blood or CSF. Blood cultures can be sterile in as many as 15% to 33% of newborns with meningitis.[1]

Other laboratory findings that are indicative of an infection but non-specific to GBS include elevated WBC and abnormal findings in the CSF analysis. Thrombocytopenia might occur in the case of sepsis.

References

  1. 1.0 1.1 1.2 Verani J.R., McGee L, and Schrag S.J. Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from CDC, 2010.CDC.gov

Template:Bacterial diseases


Template:WikiDoc Sources